Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease

Gastroenterology

Volumn 146, Issue 2, 2014, Pages

  Ordás, Ingrid ^a   Rimola, Jordi ^a   Rodríguez, Sonia ^a   Paredes, José M ^b   Martínez Pérez, María J ^b   Blanc, Esther ^b   Arévalo, Juan A ^c   Aduna, Marta ^c   Andreu, Montserrat ^d   Radosevic, Alexander ^d   Ramírez Morros, Anna M ^a   Pinó, Susana ^a   Gallego, Marta ^a   Jauregui Amezaga, Aranzazu ^a   Ricart, Elena ^a   Panés, Julián ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c Basque Centre for Blood Transfusion and Human Tissues   (Spain)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

Inflammatory Bowel Diseases; Measurement; Patient Management; TNF

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CONTRAST MEDIUM; CORTICOSTEROID; GADOLINIUM; MANNITOL; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLONOSCOPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; CROHN DISEASE ENDOSCOPIC INDEX OF SEVERITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EFFECT SIZE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; ILEOCOLONOSCOPY; INTESTINE MUCOSA; INTESTINE ULCER; ISCHEMIC COLITIS; MAGNETIC RESONANCE ENTEROGRAPHY; MAGNETIC RESONANCE INDEX OF ACTIVITY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER HEALING; ULCERATIVE COLITIS;

C-REACTIVE PROTEIN; CD; CDAI; CDEIS; CORTICOSTEROIDS; CROHN'S DISEASE; CROHN'S DISEASE ACTIVITY INDEX; CROHN'S DISEASE ENDOSCOPIC INDEX OF SEVERITY; CRP; CS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE ENTEROGRAPHY; MAGNETIC RESONANCE INDEX OF ACTIVITY; MARIA; MEASUREMENT; MH; MRE; MUCOSAL HEALING; PATIENT MANAGEMENT; TNF; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; COLON; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; ILEUM; INDUCTION CHEMOTHERAPY; INTESTINAL MUCOSA; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892723364     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.055     Document Type: Article

References (32)

1. K.F. Froslie, J. Jahnsen, and B.A. Moum et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort Gastroenterology 133 2007 412 422
2. I.C. Solberg, I. Lygren, and J. Jahnsen et al. Mucosal healing after initial treatment may be a prognostic marker for long-term outcome in inflammatory bowel disease Gut 57 2008 A15
3. F. Baert, L. Moortgat, and G. Van Assche et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease Gastroenterology 138 2010 463 468 quiz e10-e11
4. F. Schnitzler, H. Fidder, and M. Ferrante et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease Inflamm Bowel Dis 15 2009 1295 1301
5. C.G. Af Bjorkesten, U. Nieminen, and T. Sipponen et al. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease Scand J Gastroenterol 48 2013 543 551
6. J.F. Colombel, P. Rutgeerts, and W.J. Sandborn Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease: data from EXTEND Am J Gastroenterol 105 2010 S434 S435
7. M. Allez, M. Lemann, and J. Bonnet et al. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy Am J Gastroenterol 97 2002 947 953
8. P. Rutgeerts, R.H. Diamond, and M. Bala et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointest Endosc 63 2006 433 442 quiz 464
9. J.F. Colombel, W.J. Sandborn, and W. Reinisch et al. Infliximab, azathioprine, or combination therapy for Crohn's disease N Engl J Med 362 2010 1383 1395
10. M. Lemann, J.Y. Mary, and J.F. Colombel et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine Gastroenterology 128 2005 1812 1818
11. J. Rimola, S. Rodriguez, and O. Garcia-Bosch et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease Gut 58 2009 1113 1120
12. J. Rimola, I. Ordas, and S. Rodriguez et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity Inflamm Bowel Dis 17 2011 1759 1768
13. A. Oussalah, V. Laurent, and O. Bruot et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease Gut 59 2010 1056 1065
14. M.J. Steward, S. Punwani, and I. Proctor et al. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index Eur J Radiol 81 2012 2080 2088
15. J.C. Gregor, J.W. McDonald, and N. Klar et al. An evaluation of utility measurement in Crohn's disease Inflamm Bowel Dis 3 1997 265 276
16. J.Y. Mary, and R. Modigliani Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID) Gut 30 1989 983 989
17. X. Hebuterne, M. Lemann, and Y. Bouhnik et al. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Gut 62 2013 201 208
18. J.L. Mary, M. Colombel, and J. Lerebours et al. Endoscopic remission and response in Crohn's disease: an objective definition using the CDEIS Gut 54 Suppl VII 2005 A50
19. R.C. Semelka, J.P. Shoenut, and R. Silverman et al. Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences J Magn Reson Imaging 1 1991 625 632
20. G. Guyatt, S. Walter, and G. Norman Measuring change over time: assessing the usefulness of evaluative instruments J Chronic Dis 40 1987 171 178
21. R.A. Deyo, P. Diehr, and D.L. Patrick Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation Control Clin Trials 12 Suppl 1991 142S 158S
22. J.J. Bartko Measures of agreement: a single procedure Stat Med 13 1994 737 745
23. M.S. Kramer, and A.R. Feinstein Clinical biostatistics. LIV. The biostatistics of concordance Clin Pharmacol Ther 29 1981 111 123
24. J. Panes, R. Bouzas, and M. Chaparro et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease Aliment Pharmacol Ther 34 2011 125 145
25. C. Cellier, T. Sahmoud, and E. Froguel et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. a prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives Gut 35 1994 231 235
26. P. Rutgeerts, G. Van Assche, and W.J. Sandborn et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial Gastroenterology 142 2012 1102 1111
27. D.H. Bruining, E.V. Loftus Jr., and E.C. Ehman et al. Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease Clin Gastroenterol Hepatol 9 2011 679-683 e1
28. G. Van Assche, K.A. Herrmann, and E. Louis et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease J Crohns Colitis 7 2013 950 957
29. J.M. Paredes, T. Ripolles, and X. Cortes et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease Dig Dis Sci 55 2010 404 410
30. Y.W. Wu, Y.H. Tang, and N.X. Hao et al. Crohn's disease: CT enterography manifestations before and after treatment Eur J Radiol 81 2012 52 59
31. S.M. Madsen, H.S. Thomsen, and P. Schlichting et al. Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging Abdom Imaging 24 1999 232 239
32. J. Jones, E.V. Loftus Jr., and R. Panaccione et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease Clin Gastroenterol Hepatol 6 2008 1218 1241